Related Experiment Video
Updated: May 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion
Minsoo Kim1, Soomin Yoon, Sukmook Lee
1Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Chongno-gu, Seoul, Republic of Korea.
Abstract:
Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in various cancerous tissues but its role in carcinogenesis has not been established. Here, we report that gremlin-1 binds various cancer cell lines and this interaction is inhibited by our newly developed gremlin-1 antibody, GRE1. Gremlin-1 binding to cancer cells was unaffected by the presence of BMP-2, BMP-4, and BMP-7. In addition, the binding was independent of vascular endothelial growth factor receptor-2 (VEGFR2) expression on the cell surface. Addition of gremlin-1 to A549 cells induced a fibroblast-like morphology and decreased E-cadherin expression. In a scratch wound healing assay, A549 cells incubated with gremlin-1 or transfected with gremlin-1 showed increased migration, which was inhibited in the presence of the GRE1 antibody. Gremlin-1 transfected A549 cells also exhibited increased invasiveness as well as an increased growth rate. These effects were also inhibited by the addition of the GRE1 antibody. In conclusion, this study demonstrates that gremlin-1 directly interacts with cancer cells in a BMP- and VEGFR2-independent manner and can induce cell migration, invasion, and proliferation.
Insights
Gremlin-1 protein directly interacts with cancer cells, promoting migration, invasion, and proliferation. A novel antibody, GRE1, effectively inhibits these cancer-promoting effects, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in many cancers.
- Its specific role in cancer development (carcinogenesis) remains largely unestablished.
Purpose of the Study:
- To investigate the direct interaction of gremlin-1 with cancer cells.
- To determine the functional consequences of this interaction on cancer cell behavior.
- To evaluate the efficacy of a novel gremlin-1 antibody (GRE1) in blocking these effects.
Main Methods:
- Assessing gremlin-1 binding to various cancer cell lines.
- Utilizing a newly developed gremlin-1 antibody (GRE1) to inhibit binding.
- Evaluating the impact of gremlin-1 on cell morphology, E-cadherin expression, and cell migration (scratch wound healing assay).
- Assessing the effects of gremlin-1 on cell invasiveness and proliferation.
Main Results:
- Gremlin-1 directly binds to cancer cells independently of BMPs (BMP-2, BMP-4, BMP-7) and VEGFR2.
- Gremlin-1 induces fibroblast-like morphology, decreases E-cadherin expression, and enhances cell migration, invasion, and proliferation in A549 cells.
- The GRE1 antibody successfully inhibited gremlin-1-induced cell migration, invasion, and proliferation.
Conclusions:
- Gremlin-1 directly interacts with cancer cells through a BMP- and VEGFR2-independent mechanism.
- Gremlin-1 promotes key hallmarks of cancer: migration, invasion, and proliferation.
- The GRE1 antibody demonstrates potential as a therapeutic agent by neutralizing gremlin-1's pro-cancer effects.
Related Concept Videos
TGF - β Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

